Mak Peter H K, Irwin Michael G
Department of Anaesthesiology, Queen Mary Hospital, University of Hong Kong, Pokfulam, Hong Kong, Taiwan ROC.
J Clin Anesth. 2004 Mar;16(2):83-7. doi: 10.1016/j.jclinane.2003.05.004.
To demonstrate the effect of administering a precurarizing dose of cisatracurium or rocuronium on the speed of onset of cisatracurium, and to review the possible mechanisms and value of the priming principle.
Double-blind, randomized, controlled trial.
Inpatient anesthesia in a university teaching hospital.
90 ASA physical status I and II patients undergoing elective surgery requiring endotracheal intubation.
Three groups of 30 patients each were investigated. Following induction of anesthesia with fentanyl and propofol, Group 1 received cisatracurium 0.015 mg.k(-1), Group 2 received rocuronium 0.09 mg. kg(-1), and Group 3 (control) received normal saline. Six minutes after priming, Groups 1 and 2 received cisatracurium 0.135 mg. kg(-1) whereas Group 3 received cisatracurium 0.15 mg. kg(-1).
In each group, first twitch height and the train-of-four ratios were recorded every 10 seconds after the initial priming dose. Intubation was attempted after the first twitch height became less than 15% of baseline. The decrease in the train-of-four ratios at 6 minutes was 0.97 for cisatracurium and 0.85 for rocuronium. The onset of muscle relaxation was significantly faster after priming with cisatracurium and rocuronium (71.7 +/- 21.3 and 65 +/- 19.8 sec, respectively) compared with control (148.7 +/- 43.1 sec). Females receiving both muscle relaxants had a faster onset of paralysis than did males (65.9 +/- 20.6 vs. 79.2 +/- 20.6 and 55 +/- 14.5 vs. 71.7 +/- 20.4 sec). Intubation conditions were either excellent or satisfactory in all patients.
Six minutes after precurarization, there is no significant difference between rocuronium and cisatracurium when used as priming drugs. An even faster onset time with both drugs was demonstrated in females. The use of priming doses of 25% to 30% of ED(95) may cause symptomatic muscle weakness. The mechanisms of the priming principle are discussed.
证明给予顺式阿曲库铵或罗库溴铵预箭毒化剂量对顺式阿曲库铵起效速度的影响,并探讨预注原则的可能机制和价值。
双盲、随机、对照试验。
大学教学医院的住院麻醉。
90例美国麻醉医师协会(ASA)身体状况为I级和II级、接受需要气管插管的择期手术的患者。
每组30例患者,共三组。在使用芬太尼和丙泊酚诱导麻醉后,第1组接受顺式阿曲库铵0.015mg·kg⁻¹,第2组接受罗库溴铵0.09mg·kg⁻¹,第3组(对照组)接受生理盐水。预注6分钟后,第1组和第2组接受顺式阿曲库铵0.135mg·kg⁻¹,而第3组接受顺式阿曲库铵0.15mg·kg⁻¹。
每组在初始预注剂量后每10秒记录一次单刺激颤搐高度和四个成串刺激比值。当单刺激颤搐高度降至基线的15%以下时尝试插管。顺式阿曲库铵在6分钟时四个成串刺激比值的下降为0.97,罗库溴铵为0.85。与对照组(148.7±43.1秒)相比,顺式阿曲库铵和罗库溴铵预注后肌肉松弛的起效明显更快(分别为71.7±21.3秒和65±19.8秒)。接受两种肌肉松弛剂的女性麻痹起效比男性更快(65.9±20.6秒对79.2±20.6秒,55±14.5秒对71.7±20.4秒)。所有患者的插管条件均为优或良。
预箭毒化6分钟后,罗库溴铵和顺式阿曲库铵作为预注药物时无显著差异。两种药物在女性中的起效时间甚至更快。使用ED₉₅的25%至30%作为预注剂量可能会导致有症状的肌无力。讨论了预注原则的机制。